Literature DB >> 17403261

Biological therapy and nail psoriasis.

Monica Lawry1.   

Abstract

Nail psoriasis affects 50% of psoriasis patients and in many cases causes impairment of manual dexterity, pain, and psychologic stress. Despite the fact that about 80% of psoriatic arthritis patients have nail involvement, patients rarely receive treatment for nail disease. Because of great difficulty in drug delivery to site of action and significant toxicities of most conventional systemic therapies, treatment of nail psoriasis can be very challenging. Biological therapy for psoriasis and psoriatic arthritis is now widely used, and early evidence indicates it may have significant benefit for some patients with psoriatic nail disease. This article reviews the clinical manifestations of nail psoriasis and discusses how to use specific biologic therapies that may provide significant new treatment options for this challenging disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17403261     DOI: 10.1111/j.1529-8019.2007.00112.x

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  15 in total

1.  Incidence, clinical manifestations and clipping of nail psoriasis in the dermatology center of the Hospital Universitário Evangélico de Curitiba.

Authors:  Luiz Eduardo Fabricio de Melo Garbers; Helena Slongo; Lincoln Helder Zambaldi Fabricio; Juliano Vilaverde Schmitt; Aguinaldo Bonalumi
Journal:  An Bras Dermatol       Date:  2016 May-Jun       Impact factor: 1.896

Review 2.  [Nail psoriasis--an ignored disorder. Pathogenesis, diagnosis and therapy].

Authors:  C Kahl; B Hansen; K Reich
Journal:  Hautarzt       Date:  2012-03       Impact factor: 0.751

Review 3.  [The skin and rheumatism].

Authors:  S Ständer; R J Ludwig; D Thaçi
Journal:  Orthopade       Date:  2019-11       Impact factor: 1.087

4.  A Comparison of The Effects of Clobetasol 0.05% and Photodynamic Therapy Using Aminolevulinic Acid With Red Light in the Treatment of Severe Nail Psoriasis.

Authors:  Zohreh Tehranchinia; Nasibeh Barzkar; Seyed Mohammad Riahi; Marjan Khazan
Journal:  J Lasers Med Sci       Date:  2020-01-18

5.  Nail psoriasis: clinical presentation and best practice recommendations.

Authors:  Felicity Edwards; David de Berker
Journal:  Drugs       Date:  2009       Impact factor: 9.546

6.  Infliximab in the treatment of plaque type psoriasis.

Authors:  Rosita Saraceno; Andrea Saggini; Lucia Pietroleonardo; Sergio Chimenti
Journal:  Clin Cosmet Investig Dermatol       Date:  2009-04-03

7.  Assessing the Impact of Efalizumab on Nail, Scalp and Palmoplantar Psoriasis and on Quality of Life: Results from a Multicentre, Open-label, Phase IIIb/IV Trial.

Authors:  Andreas Katsambas; Ketty Peris; Gino Vena; Peter Freidmann; Gottfried Wozel; Esteban Daudén; Daiana Licu; Mauro Placchi; Michel De La Brassinne
Journal:  Arch Drug Inf       Date:  2009-12

8.  Nail psoriasis as a severity indicator: results from the PsoReal study.

Authors:  Marc A Radtke; Anna K Langenbruch; Ines Schäfer; Katharina Herberger; Kristian Reich; Matthias Augustin
Journal:  Patient Relat Outcome Meas       Date:  2010-12-22

Review 9.  Challenging regional psoriasis and ustekinumab biotherapy: impact of the patterns of disease.

Authors:  Trinh Hermanns-Lê; Enzo Berardesca; Gérald E Piérard; Marianne Lesuisse; Claudine Piérard-Franchimont
Journal:  J Biomed Biotechnol       Date:  2012-08-13

10.  Joint and nail involvement in Turkish patients with psoriatic arthritis.

Authors:  Mehmet Soy; Nuran Karaca; Elif Uğur Umit; Cemal Bes; Süleyman Piskin
Journal:  Rheumatol Int       Date:  2008-08-15       Impact factor: 3.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.